Cetera Investment Advisers
PBH icon

Cetera Investment Advisers’s Prestige Consumer Healthcare PBH Stock Holding History

Cetera Investment Advisers’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$559K Sell
11,823
-4,148
-26% -$213K ﹤0.01% 3593
2026
Q1 		$947K Buy
15,971
+5,090
+47% +$330K ﹤0.01% 2952
2025
Q4 		$671K Buy
10,881
+357
+3% +$21.9K ﹤0.01% 3186
2025
Q3 		$657K Buy
10,524
+1,835
+21% +$128K ﹤0.01% 3156
2025
Q2 		$694K Buy
8,689
+3,596
+71% +$301K ﹤0.01% 2705
2025
Q1 		$438K Sell
5,093
-196
-4% -$16.1K ﹤0.01% 2949
2024
Q4 		$413K Buy
+5,289
New +$411K ﹤0.01% 2837

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cetera Investment Advisers's PBH Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Prestige Consumer Healthcare (PBH) stake by 26% in Q2 2026, selling an estimated $213K and leaving 11,823 shares worth $559K. The position accounts for ﹤0.01% of the portfolio, ranked #3593.

Cetera Investment Advisers first reported a position in PBH in Q4 2024 and has held it in 7 quarters since. The position peaked at $947K in Q1 2026. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Cetera Investment Advisers held 11,823 shares of Prestige Consumer Healthcare worth $559K as of Q2 2026.
  • Cetera Investment Advisers sold 4,148 Prestige Consumer Healthcare shares in Q2 2026, an estimated $213K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3593 holding.
  • Cetera Investment Advisers first reported a position in Prestige Consumer Healthcare in Q4 2024 and has held it in 7 quarters since.
  • Cetera Investment Advisers's Prestige Consumer Healthcare position peaked at $947K in Q1 2026.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.